Back

Which is the best choice? One year persistence of ramipril, ramipril/amlodipin free and fixed dose combination therapy in hypertension

27 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Hypertension drug treatment Treatment of hypertension ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Gabor Antal Simonyi

St Imre University Teaching Hospital, Budapest (Hungary)

6 More presentations in this session

Presentation thumbnail
Professor S. Shehata (El-Minya, EG)
Abstract Slides
Presentation thumbnail
Professor S. Omboni (Solbiate Arno, IT)
Abstract Slides
Presentation thumbnail
Professor A. Konradi (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Mrs K. Simbirtseva (Kyiv, UA)
Abstract Slides
Presentation thumbnail
Doctor K. Stricker (Basel, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Hypertension drug treatment

The Event

Event poster

ESC Congress 2017

27 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Single pill regimen improves persistence and leads lo better clinical outcome compared to identical multi pill combination. Results of START, a German claims data analysis
30 August 2020
thumbnail
Webinar
CHT-CCP Webinar: Translating the hypertension guidelines in our daily practice: a case-based clinical approach
28 May 2020
thumbnail
Congress Presentation
Vascular stiffness parameters as additional criteria for the effectiveness of antihypertensive therapy when switching from free combinations to a fixed triple combination
21 May 2023
thumbnail
Congress Presentation
Quadruple single-pill combination in hypertension management: a novel solution for resistant patients
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources